Quarterly report pursuant to Section 13 or 15(d)

Schedule of net loss per common share (Details)

v3.22.2
Schedule of net loss per common share (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Net loss $ (2,921,341) $ (2,537,514) $ (1,124,549) $ (1,276,138) $ (5,458,855) $ (2,400,687)
Weighted Average Outstanding Shares:            
Outstanding shares 44,921,870   44,489,853   44,795,625 44,226,936
Option shares includable [1] 0   0   0 0
  44,921,870   44,489,853   44,795,625 44,226,936
Net loss per share            
Basic $ (0.07)   $ (0.03)   $ (0.12) $ (0.05)
Diluted $ (0.07)   $ (0.03)   $ (0.12) $ (0.05)
Restricted Stock [Member]            
Net loss per share            
Antidilutive Securities excluded from computation of earnings per share, amount 950,000   1,000.00   950,000 1,000,000
Employee Stock [Member]            
Net loss per share            
Antidilutive Securities excluded from computation of earnings per share, amount 137,539   224,336   166,441 214,132
Common Stock [Member]            
Net loss    
Weighted Average Outstanding Shares:            
Outstanding shares 44,921,870   44,489,853   44,795,625 44,226,936
[1] For the three months ended June 30, 2022, and 2021, option shares of 137,539 and 224,336 respectively, were not included as the impact is anti-dilutive.  For the six months ended June 30, 2022, and 2021, option shares of 166,441 and 214,132 respectively, were not included as the impact is anti-dilutive.